Latest News & Stories

Case by Case: Six New Social and Behavioral Research Case Studies
Our Social and Behavioral Research Grants Program funds locally led research to explore the social and behavioral drivers of vaccine acceptance and demand in low- and middle-income countries.

Global Health Leader Dr. Rebecca Martin to Become President of Global Immunization
Recognized internationally for her leadership in developing and implementing immunization programs and strengthening health systems, Martin will become Sabin’s President of Global Immunization effective July 21.

Q&A: Behind the Marburg Virus Outbreak in Rwanda
Sabin’s rapid delivery of investigational vaccines during Rwanda’s Marburg outbreak showcased exceptional coordination among all the partners. This Q&A unpacks the timeline, Sabin’s role, the clinical trial, the vaccine candidate, and key lessons for future collaborations.
Local Impact, Global Change
Explore how Sabin’s partners drive impact on the ground. Discover their stories here, and check back for updates on new locations and projects.
Confronting Deadly Diseases
Vaccines are our best defense against disease. Yet, we still have lethal diseases that need a vaccine solution urgently. Sabin’s R&D team is tackling two such threats: Sudan ebolavirus and Marburg virus disease. There are no approved vaccines for either of these viruses which have left behind a trail of outbreaks, ending many lives and livelihoods in Africa. Sabin’s vaccines are in Phase 2 clinical trials in Uganda and Kenya.
Making a Case for Vaccines

We make vaccines more accessible, enable innovation and expand immunization across the globe.